Applied dna reports fourth quarter and full fiscal year 2021 financial results, continuing momentum in diagnostic testing

Stony brook, n.y.--(business wire)---- $apdn #covid19testing--- fq4 revenues of $3.0 million, up 868% over fq4'20 and up 79% over fq3'21; record full-year revenues of $9.0 million, up 367% over fiscal 2020 -

APDN Ratings Summary

APDN Quant Ranking